Standout Papers

Estimates of the cancer incidence and mortality in Europe in 2006 2003 2026 2010 2018 3.0k
  1. Estimates of the cancer incidence and mortality in Europe in 2006 (2007)
    Jacques Ferlay, Philippe Autier et al. Annals of Oncology
  2. Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review (2005)
    Aimée R. Kreimer, Gary M. Clifford et al. Cancer Epidemiology Biomarkers & Prevention
  3. Cancer incidence and mortality in Europe, 2004 (2005)
    Peter Boyle, Jacques Ferlay Annals of Oncology
  4. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure (2004)
    Sara Gandini, Francesco Sera et al. European Journal of Cancer
  5. Lower Urinary Tract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7) (2003)
    Raymond C. Rosen, Jens E. Altwein et al. European Urology
  6. Cancer incidence and mortality in Europe (1989)
    Fabio Levi, Patrick Maisonneuve et al. Sozial- und Präventivmedizin
  7. Development and Validation of a Food Frequency Questionnaire in Spain (1993)
    José M. Martin‐Moreno, Peter Boyle et al. International Journal of Epidemiology
  8. Overview of the main outcomes in breast-cancer prevention trials (2003)
    Jack Cuzick, T.J. Powles et al. The Lancet
  9. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study (1999)
    Patrick Maisonneuve, Lawrence Y. Agodoa et al. The Lancet
  10. Tobacco smoking and cancer: A meta‐analysis (2007)
    Sara Gandini, Edoardo Botteri et al. International Journal of Cancer
  11. The Arabidopsis NPR1 Protein Is a Receptor for the Plant Defense Hormone Salicylic Acid (2012)
    Yue Wu, Di Zhang et al. Cell Reports
  12. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women (1998)
    Umberto Veronesi, Patrick Maisonneuve et al. The Lancet
  13. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia (2002)
    Claus G. Roehrborn, Peter Boyle et al. Urology
  14. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi (2004)
    Sara Gandini, Francesco Sera et al. European Journal of Cancer
  15. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling (2011)
    Hongcang Gu, Zachary D. Smith et al. Nature Protocols
  16. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors (2005)
    Sara Gandini, Francesco Sera et al. European Journal of Cancer
  17. Triple-negative breast cancer: epidemiological considerations and recommendations (2012)
    Peter Boyle Annals of Oncology
  18. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis (2012)
    Mathieu Boniol, Philippe Autier et al. BMJ

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 92 standout
Sub-graph 1 of 23

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The Rapid Rise in Cutaneous Melanoma Diagnoses
2021 Standout
18 intermediate papers

Works of Peter Boyle being referenced

Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis
2012 Standout
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure
2004 Standout
and 18 more

Author Peers

Author Last Decade Papers Cites
Peter Boyle 13554 8330 4153 7900 618 42.5k
Hans‐Olov Adami 16455 9457 5579 6879 661 47.1k
Ian M. Thompson 6072 20094 1697 6934 883 36.5k
Lars Holmberg 11491 9658 2298 4033 527 31.1k
Andrew J. Vickers 6216 16649 2846 4797 726 46.7k
Michael W. Kattan 9320 31082 1496 6844 790 51.3k
Scott M. Lippman 12512 10375 916 13300 520 36.3k
Graham G. Giles 8467 4388 4604 5642 770 31.1k
David E. Neal 5564 7394 1101 8299 536 21.8k
Malcolm C. Pike 10196 4110 4622 5667 402 32.6k
Brian E. Henderson 9514 4880 6095 11269 670 42.1k

All Works

Loading papers...

Rankless by CCL
2026